294 related articles for article (PubMed ID: 29946775)
1. The Multifaceted Metabolism of Glioblastoma.
Quinones A; Le A
Adv Exp Med Biol; 2018; 1063():59-72. PubMed ID: 29946775
[TBL] [Abstract][Full Text] [Related]
2. The Multifaceted Glioblastoma: From Genomic Alterations to Metabolic Adaptations.
Quinones A; Le A
Adv Exp Med Biol; 2021; 1311():59-76. PubMed ID: 34014534
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
Patil V; Mahalingam K
Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma multiforme: Metabolic differences to peritumoral tissue and IDH-mutated gliomas revealed by mass spectrometry imaging.
Kampa JM; Kellner U; Marsching C; Ramallo Guevara C; Knappe UJ; Sahin M; Giampà M; Niehaus K; Bednarz H
Neuropathology; 2020 Dec; 40(6):546-558. PubMed ID: 32662157
[TBL] [Abstract][Full Text] [Related]
5. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
[TBL] [Abstract][Full Text] [Related]
6. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma: pathology, molecular mechanisms and markers.
Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A
Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888
[TBL] [Abstract][Full Text] [Related]
8. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.
Anjum K; Shagufta BI; Abbas SQ; Patel S; Khan I; Shah SAA; Akhter N; Hassan SSU
Biomed Pharmacother; 2017 Aug; 92():681-689. PubMed ID: 28582760
[TBL] [Abstract][Full Text] [Related]
9. Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade glioma.
Mineo JF; Bordron A; Baroncini M; Maurage CA; Ramirez C; Siminski RM; Berthou C; Dam Hieu P
J Neurooncol; 2007 Dec; 85(3):281-7. PubMed ID: 17571214
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells.
Petővári G; Dankó T; Krencz I; Hujber Z; Rajnai H; Vetlényi E; Raffay R; Pápay J; Jeney A; Sebestyén A
Pathol Oncol Res; 2020 Jan; 26(1):23-33. PubMed ID: 31187466
[TBL] [Abstract][Full Text] [Related]
11. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
Nana AW; Yang PM; Lin HY
Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
[TBL] [Abstract][Full Text] [Related]
12. The Glioblastoma Microenvironment: Morphology, Metabolism, and Molecular Signature of Glial Dynamics to Discover Metabolic Rewiring Sequence.
Virtuoso A; Giovannoni R; De Luca C; Gargano F; Cerasuolo M; Maggio N; Lavitrano M; Papa M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804873
[TBL] [Abstract][Full Text] [Related]
13. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
[No Abstract] [Full Text] [Related]
14. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
15. Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.
Karunasena E; McIver LJ; Rood BR; Wu X; Zhu H; Bavarva JH; Garner HR
Oncotarget; 2014 Aug; 5(15):6003-14. PubMed ID: 25153720
[TBL] [Abstract][Full Text] [Related]
16. Molecular and Genomic Alterations in Glioblastoma Multiforme.
Crespo I; Vital AL; Gonzalez-Tablas M; Patino Mdel C; Otero A; Lopes MC; de Oliveira C; Domingues P; Orfao A; Tabernero MD
Am J Pathol; 2015 Jul; 185(7):1820-33. PubMed ID: 25976245
[TBL] [Abstract][Full Text] [Related]
17. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
[TBL] [Abstract][Full Text] [Related]
18. Metabolic therapy: a new paradigm for managing malignant brain cancer.
Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
[TBL] [Abstract][Full Text] [Related]
19. MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.
Liu YS; Lin HY; Lai SW; Huang CY; Huang BR; Chen PY; Wei KC; Lu DY
Oncogene; 2017 Aug; 36(35):5006-5022. PubMed ID: 28459461
[TBL] [Abstract][Full Text] [Related]
20. Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.
Agnihotri S; Aldape KD; Zadeh G
Neurosurg Focus; 2014 Dec; 37(6):E13. PubMed ID: 25434382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
